Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990393830> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2990393830 abstract "Background: GB001 is an oral antagonist of the prostaglandin D2 receptor 2 (DP2). DP2 is expressed on a variety of cells including Th2 and eosinophils. DP2 antagonists may inhibit recruitment of airway eosinophils, with consequent reduction in airway inflammation. Objectives: Characterize the effect of GB001 on markers of asthma control including FEV1 using baseline fractional exhaled nitric oxide (FeNO) and blood eosinophil (Eos) thresholds in post-hoc analysis. Methods: In this study 36 subjects with mild atopic asthma were randomized (2:1) to 30 mg of GB001 or placebo once daily for 28 days. Subjects received a total daily dose of FP ≤500 mcg or equivalent. FEV1 was measured at visits including baseline and on Days 2, 7, 14 and 28. Outcomes were analyzed by baseline FeNO ( Results: Mean age was 34.6 years, 92% male, and 92% Caucasian. Mean baseline FEV1 was 3,789 ml. In the overall population, GB001 had a numeric effect on FEV1 at Day 28 (difference in mean change for GB001 vs placebo of 102 ml, n=35). Greater effects on FEV1 were observed in the high baseline FeNO and Eos subgroups (differences of 207 ml, n=13 and 133 ml, n=11, respectively). These effects were observed as early as Day 2 (difference of 229 and 163 ml for high baseline FeNO and Eos subgroups, respectively) and were sustained through completion of treatment on Day 28. No safety signals were identified. Conclusions: These results suggest that GB001 may have a rapid and sustained effect on lung function in subjects with markers of eosinophilic inflammation. Prospective studies are needed to confirm these findings." @default.
- W2990393830 created "2019-12-05" @default.
- W2990393830 creator A5052993573 @default.
- W2990393830 creator A5058416167 @default.
- W2990393830 creator A5068917661 @default.
- W2990393830 creator A5070084615 @default.
- W2990393830 creator A5075962701 @default.
- W2990393830 date "2019-09-28" @default.
- W2990393830 modified "2023-09-27" @default.
- W2990393830 title "Markers of eosinophilic inflammation are associated with response to the DP2 antagonist GB001 in patients with mild atopic asthma" @default.
- W2990393830 doi "https://doi.org/10.1183/13993003.congress-2019.pa3713" @default.
- W2990393830 hasPublicationYear "2019" @default.
- W2990393830 type Work @default.
- W2990393830 sameAs 2990393830 @default.
- W2990393830 citedByCount "0" @default.
- W2990393830 crossrefType "proceedings-article" @default.
- W2990393830 hasAuthorship W2990393830A5052993573 @default.
- W2990393830 hasAuthorship W2990393830A5058416167 @default.
- W2990393830 hasAuthorship W2990393830A5068917661 @default.
- W2990393830 hasAuthorship W2990393830A5070084615 @default.
- W2990393830 hasAuthorship W2990393830A5075962701 @default.
- W2990393830 hasConcept C126322002 @default.
- W2990393830 hasConcept C142724271 @default.
- W2990393830 hasConcept C170493617 @default.
- W2990393830 hasConcept C204787440 @default.
- W2990393830 hasConcept C27081682 @default.
- W2990393830 hasConcept C2776042228 @default.
- W2990393830 hasConcept C2776885963 @default.
- W2990393830 hasConcept C2777037409 @default.
- W2990393830 hasConcept C2780333948 @default.
- W2990393830 hasConcept C2781142857 @default.
- W2990393830 hasConcept C2908647359 @default.
- W2990393830 hasConcept C71924100 @default.
- W2990393830 hasConcept C90924648 @default.
- W2990393830 hasConcept C99454951 @default.
- W2990393830 hasConceptScore W2990393830C126322002 @default.
- W2990393830 hasConceptScore W2990393830C142724271 @default.
- W2990393830 hasConceptScore W2990393830C170493617 @default.
- W2990393830 hasConceptScore W2990393830C204787440 @default.
- W2990393830 hasConceptScore W2990393830C27081682 @default.
- W2990393830 hasConceptScore W2990393830C2776042228 @default.
- W2990393830 hasConceptScore W2990393830C2776885963 @default.
- W2990393830 hasConceptScore W2990393830C2777037409 @default.
- W2990393830 hasConceptScore W2990393830C2780333948 @default.
- W2990393830 hasConceptScore W2990393830C2781142857 @default.
- W2990393830 hasConceptScore W2990393830C2908647359 @default.
- W2990393830 hasConceptScore W2990393830C71924100 @default.
- W2990393830 hasConceptScore W2990393830C90924648 @default.
- W2990393830 hasConceptScore W2990393830C99454951 @default.
- W2990393830 hasLocation W29903938301 @default.
- W2990393830 hasOpenAccess W2990393830 @default.
- W2990393830 hasPrimaryLocation W29903938301 @default.
- W2990393830 hasRelatedWork W1512168554 @default.
- W2990393830 hasRelatedWork W1809380315 @default.
- W2990393830 hasRelatedWork W1891992088 @default.
- W2990393830 hasRelatedWork W1922210558 @default.
- W2990393830 hasRelatedWork W1937667072 @default.
- W2990393830 hasRelatedWork W2026581655 @default.
- W2990393830 hasRelatedWork W2069863648 @default.
- W2990393830 hasRelatedWork W2075032684 @default.
- W2990393830 hasRelatedWork W2088521402 @default.
- W2990393830 hasRelatedWork W2140688081 @default.
- W2990393830 hasRelatedWork W2265572462 @default.
- W2990393830 hasRelatedWork W2374467819 @default.
- W2990393830 hasRelatedWork W2411890917 @default.
- W2990393830 hasRelatedWork W2509276970 @default.
- W2990393830 hasRelatedWork W2982379564 @default.
- W2990393830 hasRelatedWork W2990215157 @default.
- W2990393830 hasRelatedWork W2990779285 @default.
- W2990393830 hasRelatedWork W3004163127 @default.
- W2990393830 hasRelatedWork W3032451891 @default.
- W2990393830 hasRelatedWork W1906897993 @default.
- W2990393830 isParatext "false" @default.
- W2990393830 isRetracted "false" @default.
- W2990393830 magId "2990393830" @default.
- W2990393830 workType "article" @default.